H1B Salary Data

Home › Employers › TETmedical, Inc.

TETmedical, Inc.: H-1B salaries and sponsorship

TETmedical, Inc. filed 5 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $75,000.

Applications (LCAs)5
Certified3
Employer addressFair Haven, NJ
H-1B dependent employerNo
Median offered salary$75,000
Middle half of salaries$72,500–$75,000
10th–90th percentile$71,000–$75,000

Does TETmedical, Inc. sponsor H-1B visas?

TETmedical, Inc. filed 5 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 11, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Research Scientist4$75,000
Research Support Specialist1$70,000

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20244$75,000
FY20251$70,000

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Research Support Specialist$70,000
Level I
Ithaca, NYApr 11, 2025Oct 1, 2025Certified
Research Scientist$75,000
Level I
Ithaca, NYJun 10, 2024Oct 1, 2024Certified
Research Scientist$75,000
Level I
Ithaca, NYApr 24, 2024Oct 1, 2024Certified
Research Scientist—
Level I
Ithaca, NYApr 19, 2024Oct 1, 2024Denied
Research Scientist$75,000
Level I
Ithaca, NYApr 15, 2024Oct 1, 2024Denied

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).